| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2878186 | The Annals of Thoracic Surgery | 2010 | 6 Pages |
Abstract
The number of thromboembolic events after surgical ablation procedure is low and appears unrelated to the CHADS2. This, together with the higher rate of bleeding, raises questions regarding the applicability of the CHADS2 for patients after surgical ablation. A randomized study is required to define the risks and anticoagulation strategies for patients after surgical ablation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Niv MD, Linda PhD, RN, Karen PhD, Sari D. PhD, Sharon MBA,